Urology · Jackson, MS
NPI
1710418546
Since 2017
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
501 Marshall St Ste 301
Jackson, MS, 39202
Phone (601) 353-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
9,561 services
Medicare patients, 2024
890
Average age 76
Drug cost, 2024
$1.8M
2,338 prescriptions
Company payments, 2025
$1,259
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew C Moss was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 3,120 times for 31 patients. In total Matthew C Moss billed 9,561 services in 92 codes, and Medicare paid $374K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-29.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,120 | 31 | $0.10 | $321 |
| 81001 Clinical Chemistry | Office | 967 | 693 | $3.09 | $2,991 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 650 | 42 | $34.39 | $22K |
| 36415 Venipuncture Blood Collection | Office | 621 | 436 | $8.56 | $5,314 |
| 84153 Clinical Chemistry | Office | 562 | 407 | $17.83 | $10K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 492 | 56 | $140.15 | $69K |
| 99213 Office E&M - Established | Office | 411 | 333 | $59.50 | $24K |
| 99214 Office E&M - Established | Office | 399 | 317 | $89.47 | $36K |
| 99212 Office E&M - Established | Office | 295 | 246 | $36.94 | $11K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 250 | 42 | $34.39 | $8,597 |
| 51798 Ultrasound - Nonspecific | Office | 160 | 137 | $6.99 | $1,119 |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 150 | 42 | $68.80 | $10K |
| 99204 Office E&M - New | Office | 134 | 134 | $108.41 | $15K |
| 52000 Cystourethroscopy | Facility | 103 | 92 | $61.28 | $6,312 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 100 | 86 | $70.35 | $7,035 |
By year: 2022 $105K for 3,708 services; 2023 $384K for 13,706 services; 2024 $374K for 9,561 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 967 | 693 | $3.09 | $2,991 |
| 87798 Infectious Agent Detection by DNA/RNA | 650 | 42 | $34.39 | $22K |
| 36415 Venipuncture Blood Collection | 621 | 436 | $8.56 | $5,314 |
| 84153 Clinical Chemistry | 562 | 407 | $17.83 | $10K |
| 87481 Infectious Agent Detection by DNA/RNA | 250 | 42 | $34.39 | $8,597 |
| 87801 Infectious Agent Detection by DNA/RNA | 150 | 42 | $68.80 | $10K |
| 87500 Infectious Agent Detection by DNA/RNA | 50 | 42 | $34.39 | $1,720 |
| 87640 Infectious Agent Detection by DNA/RNA | 50 | 42 | $34.39 | $1,720 |
| 87641 Infectious Agent Detection by DNA/RNA | 50 | 42 | $34.39 | $1,720 |
| 87651 Infectious Agent Detection by DNA/RNA | 50 | 42 | $34.39 | $1,720 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew C Moss prescribed most often to Medicare patients was Tamsulosin Hcl, with 826 prescriptions and refills. In total Matthew C Moss wrote 2,338 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 826 | 2,109 | 287 | $12K |
| Finasteride Generic | 306 | 814 | 101 | $4,561 |
| Ciprofloxacin Hcl Generic | 161 | 161 | 137 | $570 |
| Dutasteride Generic | 95 | 250 | 29 | $4,021 |
| Bicalutamide Generic | 82 | 152 | 21 | $2,360 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 75 | 173 | 20 | $915 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 67 | 67 | 63 | $192 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 54 | 54 | 49 | $157 |
| Cephalexin Generic | 54 | 60 | 29 | $194 |
| Erleada Apalutamide | 51 | 51 | Under 11 | $705K |
| Xtandi Enzalutamide | 49 | 49 | Under 11 | $659K |
| Trelstar Triptorelin Pamoate | 44 | 239 | 27 | $205K |
| Myrbetriq Mirabegron | 39 | 43 | Under 11 | $19K |
| Gemtesa Vibegron | 39 | 47 | Under 11 | $22K |
| Ketorolac Tromethamine Generic | 30 | 30 | 28 | $259 |
Brand drugs: - claims; generic drugs: 2,086 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew C Moss $1,259 ($1,259 in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $434.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 18 | $434 |
| Dendreon Pharmaceuticals LLC | 8 | $205 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $83.98 |
| Pfizer Inc. PFE | 3 | $59.95 |
| Accord Healthcare, Inc. | 3 | $54.46 |
| Astellas Pharma US Inc 4503.T | 2 | $52.13 |
| Tolmar, Inc. | 2 | $43.55 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $43.32 |
| Axogen AXGN | 1 | $42.67 |
| C. R. Bard, Inc. & Subsidiaries BDX | 1 | $29.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.